Market openNon-fractional

Ginkgo Bioworks/DNA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Ginkgo Bioworks

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Ticker

DNA

Sector

Basic Materials

Trading on

NYSE

Industry

Chemicals

Headquarters

Boston, United States

Employees

1,218

Ginkgo Bioworks Metrics

BasicAdvanced
$837M
Market cap
-
P/E ratio
-$0.43
EPS
1.42
Beta
-
Dividend rate
$837M
1.42
5.342
5.117
23.752
23.752
-7,484.85%
-21.76%
-65.81%
3.539
0.83
0.95
-2.292
-46.49%
-55.59%
27.95%
57.94%

What the Analysts think about Ginkgo Bioworks

Analyst Ratings

Majority rating from 7 analysts.
Sell

Ginkgo Bioworks Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-437.73% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$38M
9.22%
Net income
-$166M
-21.60%
Profit margin
-437.73%
-28.22%

Ginkgo Bioworks Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 4.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.09
-$0.16
-$0.11
-$0.08
-
Expected
-$0.08
-$0.09
-$0.10
-$0.08
-$0.08
Surprise
6.78%
86.67%
13.79%
-4.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ginkgo Bioworks stock?

Ginkgo Bioworks (DNA) has a market cap of $837M as of July 05, 2024.

What is the P/E ratio for Ginkgo Bioworks stock?

The price to earnings (P/E) ratio for Ginkgo Bioworks (DNA) stock is 0 as of July 05, 2024.

Does Ginkgo Bioworks stock pay dividends?

No, Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Ginkgo Bioworks dividend payment date?

Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Ginkgo Bioworks?

Ginkgo Bioworks (DNA) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Ginkgo Bioworks stock

Buy or sell Ginkgo Bioworks stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing